FF
KURA icon

FourThought Financial’s Kura Oncology KURA Stock Holding History

FourThought Financial’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$18K Hold
1,352
– – ﹤0.01% 889
2022
Q2 		$25K Hold
1,352
– – ﹤0.01% 811
2022
Q1 		$22K Buy
1,352
+222
+20% +$3.21K ﹤0.01% 873
2021
Q4 		$16K Hold
1,130
– – ﹤0.01% 973
2021
Q3 		$21K Buy
1,130
+49
+5% +$923 ﹤0.01% 937
2021
Q2 		$22K Sell
1,081
-45
-4% -$1.12K ﹤0.01% 924
2021
Q1 		$31K Buy
1,126
+679
+152% +$21.5K ﹤0.01% 804
2020
Q4 		$14K Buy
+447
New +$15.7K ﹤0.01% 955

Other funds holding KURA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

FourThought Financial's KURA Position: Q3 2022 in Review

FourThought Financial held its Kura Oncology (KURA) position steady in Q3 2022 at 1,352 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #889.

FourThought Financial first reported a position in KURA in Q4 2020 and has held it in 8 quarters since. The position peaked at $31K in Q1 2021. 148 funds tracked by Wall St. Rank hold KURA as of Q3 2022.

  • FourThought Financial held 1,352 shares of Kura Oncology worth $18K as of Q3 2022.
  • FourThought Financial left its Kura Oncology share count unchanged in Q3 2022.
  • Kura Oncology made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #889 holding.
  • FourThought Financial first reported a position in Kura Oncology in Q4 2020 and has held it in 8 quarters since.
  • FourThought Financial's Kura Oncology position peaked at $31K in Q1 2021.
  • 148 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.